LexDanaLexDanabeta
Inventor

Hans-Ludwig Schaefer

Inventor
Hochheim, DE

Overview

41→
Patents
1981–2012
Patent span
Human necessities
Primary field (CPC A)

Patents· 41 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds5%
C07HSugars4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61QSpecific use of cosmetics or similar toiletry preparations1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07JSteroids1%
PatentTitleYear
8,173,674'Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals'20128,106,023'1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof'20128,101,583'1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof'20128,048,901'1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals'20117,956,077'2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes'20117,956,085'1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof'20117,923,468'1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof'20117,910,612'4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use'20117,872,034'Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals'20117,858,647'N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use'20107,772,429'Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use'20107,732,471'6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof'20107,671,047'Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20107,615,536'1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic'20097,601,863'Use of PPAR agonists for the treatment of congestive heart failure'20097,598,281'Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes'20097,579,339'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20097,541,464'7-azaindoles, pharmaceutical compositions and their therapeutic applications'20097,538,131'2-{-3-′2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes'20097,468,369'Sulfonyl pyrrolidines, method for producing the same and their use as drugs'20087,407,938'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20087,390,790'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20087,388,004'Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20087,365,084'Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals'20087,335,671'Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals'20087,259,177'Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals'20077,220,876'Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals'20077,205,290'Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use'20077,179,792'Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product'20077,176,193'Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20077,176,194'Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use'20077,173,151'Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals'20077,160,911'Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals'20077,148,246'Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals'20066,703,386'Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use'20046,632,838'Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia'20036,552,048'Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals'20036,498,156'Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use'20026,342,512'Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals'20025,292,512'Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product'19944,264,584'Hydrocortisone orthoesters, pharmaceutical formulations thereof and processes for the preparation thereof'1981

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1981–1994Based in Antibes, FR· patent location history
2002–2011Patents assigned to AVENTIS PHARMA GMBH (6)· patent assignee history
2002–2012Based in Hochheim, DE· patent location history
2002–2004Based in Hofheim, DE· patent location history
2006–2012Patents assigned to SANOFI AVENTIS DEUTSCHLAND (26)· patent assignee history
2008–2012Patents assigned to SANOFI AVENTIS (5)· patent assignee history
2009–2012Based in Frankfurt am Main, DE· patent location history
2012Patents assigned to SCHAEFER HANS-LUDWIG (3)· patent assignee history
2012Patents assigned to FRICK WENDELIN (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANOFI AVENTIS DEUTSCHLAND262006–2012
AVENTIS PHARMA GMBH62002–2011
SANOFI AVENTIS52008–2012
SCHAEFER HANS-LUDWIGself32012
FRICK WENDELIN22012
Locations
LocationPatentsSpan
Hochheim, DE302002–2012
Frankfurt am Main, DE72009–2012
Hofheim, DE22002–2004
Antibes, FR21981–1994